NEUROFIBROMATOSIS 2
Clinical trials for NEUROFIBROMATOSIS 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug shows promise for rare nerve tumor disorder
Disease control CompletedThis study tested the drug crizotinib in 12 people with neurofibromatosis type 2 (NF2) who had growing tumors on their hearing nerves. The goal was to see if the drug could shrink these tumors. Participants took crizotinib pills daily for up to 12 months. The study is now complet…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
Video-Based resiliency training shows promise for neurofibromatosis patients
Symptom relief CompletedThis study tested two stress and symptom management programs delivered via live video for 228 adults with neurofibromatosis (NF1, NF2, or schwannomatosis). The goal was to see if these programs could improve physical and psychological quality of life. Participants had to have dif…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 17, 2026 05:34 UTC